OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
2.520
+0.010 (0.40%)
At close: Jun 26, 2026, 4:00 PM EDT
2.470
-0.050 (-1.98%)
After-hours: Jun 26, 2026, 7:52 PM EDT
OmniAb Employees
OmniAb had 89 employees as of December 31, 2025. The number of employees decreased by 25 or -21.93% compared to the previous year.
Employees
89
Change (1Y)
-25
Growth (1Y)
-21.93%
Revenue / Employee
$325,157
Profits / Employee
-$609,955
Market Cap
365.33M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Rocket Pharmaceuticals | 202 |
| Upstream Bio | 75 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 59 |
| Atea Pharmaceuticals | 55 |
| X4 Pharmaceuticals | 45 |
| Compass Therapeutics | 39 |
OABI News
- 7 weeks ago - OmniAb reports Q1 EPS (6c), consensus (10c) - TheFly
- 7 weeks ago - OmniAb raises FY26 revenue view to $28M-$33M, consensus $28.0M - TheFly
- 7 weeks ago - OmniAb Earnings Call Transcript: Q1 2026 - Transcripts
- 7 weeks ago - OmniAb Slides: Q1 2026 - Filings
- 7 weeks ago - OmniAb Earnings release: Q1 2026 - Filings
- 7 weeks ago - OmniAb Quarterly report: Q1 2026 - Filings
- 7 weeks ago - OmniAb Reports First Quarter 2026 Financial Results and Business Highlights - Business Wire
- 2 months ago - OmniAb Proxy statement: Proxy filing - Filings